Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts

Cardiology

Volumn 113, Issue 3, 2009, Pages 161-168

  Truter, Sharada L ^c   Catanzaro, Daniel F ^a   Supino, Phyllis G ^a   Gupta, Anuj ^b   Carter, John ^a   Herrold, Edmund M ^a   Dumlao, Themy F ^d   Borer, Jeffrey S ^a,e  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NewYork Presbyterian Hospital

^c PFIZER INC   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Fibronectin; Matrix metalloproteases; Signal transduction

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGEN; FIBRONECTIN; GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE REGURGITATION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROBLAST; HEART MUSCLE FIBROSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RABBIT; ZYMOGRAPHY;

ANIMALS; AORTIC VALVE INSUFFICIENCY; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; EXTRACELLULAR MATRIX PROTEINS; FIBRINOGEN; FIBROSIS; GENE EXPRESSION; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MYOCYTES, CARDIAC; RABBITS; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 58149166309     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000187723     Document Type: Article

References (44)

1. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT: Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64:1041-1050.
2. Brilla CG, Janicki JS, Weber KT: Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991;69:107-115.
3. Weber K, Janicki J, Shroff S, Pick R, Chen R, Bashey R: Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988;62:757-765.
4. Magid N, Opio G, Wallerson D, Young M, Borer J: Heart failure due to chronic experimental aortic regurgitation. Am J Physiol 1994;267:H556-H562.
5. Borer J, Truter S, Herrold E, Falcone D, Pena M, Carter J, Dumlao T, Lee J, Supino P: Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 2002;105:1837-1842.
6. Brower GL, Gardner JD, Forman MF, Murray DB, Voloshenyuk T, Levick SP, Janicki JS: The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg 2006;30:604-610.
7. Goldfine S, Pena M, Magid N, Liu S, Borer J: Myocardial collagen in cardiac hypertrophy resulting from chronic aortic regurgitation. Am J Ther 1998;5:139-146.
8. Liu S, Magid N, Fox P, Goldfine S, Borer J: Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation. Cardiology 1998;90:101-109.
9. Leiden JM: The genetics of dilated cardiomyopathy - emerging clues to the puzzle. N Engl J Med 1997;337:1080-1081.
10. Nagase H, Woessner JF Jr: Matrix metallo-proteinases. J Biol Chem 1999;274:21491-21494.
11. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
12. Muro AF, Bernath VA, Kornblihtt AR: Interaction of the-170cyclic AMP response element with the adjacent CCAAT box in the human fibronectin gene promoter. J Biol Chem 1992;267:12767-12774.
13. Hasan S, Nakajima M: Retinoic acid synergizes with cyclic AMP to enhance MMP-2basal promoter activity. Biochem Biophys Res Commun 1999;258:663-667.
14. Li YS, Shyy JY, Li S, Lee J, Su B, Karin M, Chien S: The Ras-JNK pathway is involved in shear-induced gene expression. Mol Cell Biol 1996;16:5947-5954.
15. Tyagi SC, Lewis K, Pikes D, Marcello A, Mujumdar VS, Smiley LM, Moore CK: Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J Cell Physiol 1998;176:374-382.
16. 2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. J Clin Invest 1998;101:301-310.
17. Atance J, Yost MJ, Carver W: Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. J Cell Physiol 2004;200:377-386.
18. Magid NM, Borer JS, Young MS, Wallerson DC, De Monteiro C: Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgitation. Circulation 1993;87:1249-1257.
19. Mitra R, Morad M: A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates. Am J Physiol 1985;249:H1056-H1060.
20. Brilla CG, Zhou G, Matsubara L, Weber KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-820.
21. Rodemann H, Muller G: Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with interstitial fibrosis. Proc Soc Exp Biol Med 1990;195:57-63.
22. Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ: Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 1996;155:13-21.
23. Xu X, C hen Z, Wang Y, Yamada Y, Steffensen B: Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and-2. Biochem J 2005;392:127-134.
24. Spinale FG: Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007;87:1285-1342.
25. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839.
26. Brower GL, Henegar JR, Janicki JS: Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol 1996;271:H2071-H2078.
27. Brower GL, Chancey AL, Thanigaraj S, Mat-subara BB, Janicki JS: Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 2002;283: H518-H525.
28. Brower GL, Janicki JS: Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol 2001;280:H674-H683.
29. Borer J, Truter S, Herrold E, Supino P, Carter J, Gupta A: The cellular and molecular basis of heart failure in regurgitant valvular diseases: the myocardial extracellular matrix as a building block for future therapy. Adv Cardiol 2002;39:7-14.
30. Bernardo MM, Fridman R: TIMP-2(tissue inhibitor of metalloproteinase-2) regulates MMP-2(matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2activation by MT1(membrane type 1)-MMP. Biochem J 2003;374:739-745.
31. Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA, Fridman R: Differential roles of TIMP-4and TIMP-2in pro-MMP-2activation by MT1-MMP. Biochem Biophys Res Commun 2001;281:126-130.
32. Jo Y, Yeon J, Kim HJ, Lee ST: Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1matrix metallopro-teinase using baculovirus/insect-cell expression system. Biochem J 2000;345:511-519.
33. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH: A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1and JunB-FosB heterodimers. Biochem J 2003;369:485-496.
34. Tr uter S, Gupta A, Leer E, Huang Z, Pitlor L, Borer J: The stress-activated protein kinase pathways, C-Jun N-terminal kinase and P38-mitogen activated protein kinase, regulate fibronectin expression in aortic regurgi-tation. J Am Coll Cardiol 2005;45:353A.
35. Singhal PC, Sagar S, Garg P: Simulated glomerular pressure modulates mesangial cell 72 kDa metalloproteinase activity. Connect Tissue Res 1996;33:257-263.
36. Yasuda T, Kondo S, Homma T, Harris RC: Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells. J Clin Invest 1996;98:1991-2000.
37. Maron BJ, Ferrans VJ, Roberts WC: Myocardial ultrastructure in patients with chronic aortic valve disease. Am J Cardiol 1975;35:725-739.
38. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M: Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989;79:744-755.
39. Piper C, Schultheiss HP, Akdemir D, Rudolf J, Horstkotte D, Pauschinger M: Remodeling of the cardiac extracellular matrix differs between volume- and pressure-overloaded ventricles and is specific for each heart valve lesion. J Heart Valve Dis 2003;12:592-600.
40. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J: Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004;44:1609-1618.
41. Fielitz J, Leuschner M, Zurbrugg HR, Han-nack B, Pregla R, Hetzer R, Regitz-Zagrosek V: Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J Mol Med 2004;82:809-820.
42. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, Gillijns H, Herijgers P, Flameng W, Carmeliet P, Van de Werf F, Pinto YM, Janssens S: Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metallopro-teinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005;112:1136-1144.
43. Wolffe AP, Matzke MA: Epigenetics: regulation t hrough repression. Science 1999;286:481-486.
44. Barcellos-Hoff MH: It takes a tissue to make a tumor: epigenetics, cancer and the micro-environment. J Mammary Gland Biol Neoplasia 2001;6:213-221.